Tectonic Therapeutic, Inc.
TECX
$27.61
-$0.35-1.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -42.30% | -27.89% | -25.84% | -44.01% | -34.56% |
| Total Depreciation and Amortization | -18.98% | -16.41% | 2.65% | 12.01% | 9.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 86.06% | 69.45% | 52.50% | 65.33% | 120.09% |
| Change in Net Operating Assets | 121.65% | 99.32% | 22.04% | -135.57% | -3,069.05% |
| Cash from Operations | -4.00% | -1.69% | -15.81% | -50.09% | -60.68% |
| Capital Expenditure | -11.73% | -33.33% | -3.94% | -221.05% | -21.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.37% | 11.54% | 30.54% | -124.56% | -21.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.21% | -2.95% | -0.42% | -1.07% | -0.42% |
| Issuance of Common Stock | -97.06% | 89.62% | 42.20% | 42.34% | 707.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -114.94% | -116.76% | -118.70% | -124.47% | 13,551.08% |
| Cash from Financing | -101.12% | 0.96% | -16.67% | -21.82% | 955.04% |
| Foreign Exchange rate Adjustments | -93.65% | -1,087.50% | 20.69% | 134.09% | 205.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.16% | 0.51% | -28.11% | -39.92% | 4,794.61% |